Business Description
OncoZenge AB
ISIN : SE0015504097
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.95 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -131.1 | |||||
3-Year EPS without NRI Growth Rate | -150 | |||||
3-Year Book Growth Rate | -26.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 93.87 | |||||
9-Day RSI | 84.52 | |||||
14-Day RSI | 75.88 | |||||
6-1 Month Momentum % | 38.26 | |||||
12-1 Month Momentum % | 125.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.17 | |||||
Quick Ratio | 11.17 | |||||
Cash Ratio | 10.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.2 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -61.69 | |||||
ROA % | -56.65 | |||||
ROIC % | -146.71 | |||||
ROCE % | -61.67 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 6.5 | |||||
Price-to-Tangible-Book | 12.6 | |||||
EV-to-EBIT | -6.19 | |||||
EV-to-Forward-EBIT | -3.01 | |||||
EV-to-EBITDA | -6.19 | |||||
EV-to-Forward-EBITDA | -3.01 | |||||
EV-to-Forward-Revenue | 0.41 | |||||
EV-to-FCF | -4.69 | |||||
Price-to-Net-Current-Asset-Value | 12.6 | |||||
Price-to-Net-Cash | 13.69 | |||||
Earnings Yield (Greenblatt) % | -16.17 | |||||
FCF Yield % | -14.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
OncoZenge AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -1.011 | ||
Beta | 0 | ||
Volatility % | 80.2 | ||
14-Day RSI | 75.88 | ||
14-Day ATR (kr) | 0.609974 | ||
20-Day SMA (kr) | 6.659 | ||
12-1 Month Momentum % | 125.24 | ||
52-Week Range (kr) | 2.3 - 8.45 | ||
Shares Outstanding (Mil) | 11.71 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
OncoZenge AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
OncoZenge AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
OncoZenge AB Frequently Asked Questions
What is OncoZenge AB(OSTO:ONCOZ)'s stock price today?
When is next earnings date of OncoZenge AB(OSTO:ONCOZ)?
Does OncoZenge AB(OSTO:ONCOZ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |